Emergent Biosolutions
EBS
EBS
263 hedge funds and large institutions have $2.15B invested in Emergent Biosolutions in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 103 increasing their positions, 99 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
39% less call options, than puts
Call options by funds: $212K | Put options by funds: $348K
Holders
263
Holding in Top 10
3
Calls
$212K
Puts
$348K
Top Buyers
| 1 | +$45.5M | |
| 2 | +$14.1M | |
| 3 | +$12.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.1M |
| 5 |
Renaissance Technologies
New York
|
+$10M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$13.6M | |
| 3 | -$11.9M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$10.5M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$9.11M |